EU considers booster doses of J&J’s COVID-19 vaccine

EU considers booster doses of J&J’s COVID-19 vaccine

Amsterdam The European Medicines Agency has said it is evaluating whether booster doses of the one-off COVID-19 vaccine from Johnson & Johnson should be allowed.

In a statement on Monday, the European Union’s drug regulator said it was considering a request by J&J to recommend booster doses of the J&J vaccine for adults 18 and over, at least two months after they were first vaccinated. Amid a massive wave of new coronavirus infections across Europe, the European Energy Agency said it expects a decision on this within weeks.

The FDA gave the green light for the J&J booster doses in October, both for people who initially received the J&J vaccine and for people vaccinated with other vaccines.

J&J earlier presented results from a large study that found giving a second dose just two months after the first protected against COVID-19 symptoms to 94% of 70% in US recipients. Instead, giving this booster six months later led to an even bigger jump in anti-virus antibodies.


European Union countries initially ordered about 200 million doses of the J&J vaccine, but only a small portion were delivered after the company faced repeated production problems.

The EMA previously said that its 27 states could consider giving booster doses of vaccines made by Pfizer-BioNTech and Moderna to people who received the two-dose regimen at least six months ago, noting that the third shot will provide additional antibodies against COVID-19. The agency is expected to make a decision later this week on COVID-19 vaccines for children ages 5 to 11.


Read AP’s full coverage of the pandemic at:

Copyright 2021 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.

Leave a Reply

Your email address will not be published. Required fields are marked *